Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaby Palmer

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Is IL-1 a good therapeutic target in the treatment of arthritis?Danielle Burger, Jean-Michel Dayer, Gaby Palmer, et al.
Cytokine|July 18, 2015
The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseasesJennifer Palomo, Damien Dietrich, Praxedis Martin, et al.
Gene|August 12, 2022
Epigenetic remodeling of downstream enhancer regions is linked to selective expression of the IL1F10 gene in differentiated human keratinocytesDominique Talabot-Ayer, Alejandro Diaz-Barreiro, Ali Modarressi, et al.
Frontiers in Immunology|August 9, 2024
Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in miceArnaud Huard, Emiliana Rodriguez, Dominique Talabot-Ayer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2020
Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation SyndromeMathilde Harel, Charlotte Girard-Guyonvarc'h, Emiliana Rodriguez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2023
IL-18 Binding Protein-Producing Cells Attenuate Anemia in Murine Macrophage Activation SyndromeMathilde Harel, Sébastien Fauteux-Daniel, Emiliana Rodriguez, et al.
Plos One|March 20, 2018
The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expressionJennifer Palomo, Sabina Troccaz, Dominique Talabot-Ayer, et al.
Arthritis and Rheumatism|January 30, 2010
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonistCéline Lamacchia, Gaby Palmer, Christian A Seemayer, et al.
Frontiers in Immunology|April 2, 2021
IL-1 Family Antagonists in Mouse and Human Skin InflammationPraxedis Martin, Jérémie D Goldstein, Loïc Mermoud, et al.
Journal of Leukocyte Biology|October 21, 2011
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promotersDominique Talabot-Ayer, Nicolas Calo, Solenne Vigne, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Is IL-1 a good therapeutic target in the treatment of arthritis?Danielle Burger, Jean-Michel Dayer, Gaby Palmer, et al.
Cytokine|July 18, 2015
The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseasesJennifer Palomo, Damien Dietrich, Praxedis Martin, et al.
Gene|August 12, 2022
Epigenetic remodeling of downstream enhancer regions is linked to selective expression of the IL1F10 gene in differentiated human keratinocytesDominique Talabot-Ayer, Alejandro Diaz-Barreiro, Ali Modarressi, et al.
Frontiers in Immunology|August 9, 2024
Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in miceArnaud Huard, Emiliana Rodriguez, Dominique Talabot-Ayer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2020
Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation SyndromeMathilde Harel, Charlotte Girard-Guyonvarc'h, Emiliana Rodriguez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2023
IL-18 Binding Protein-Producing Cells Attenuate Anemia in Murine Macrophage Activation SyndromeMathilde Harel, Sébastien Fauteux-Daniel, Emiliana Rodriguez, et al.
Plos One|March 20, 2018
The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expressionJennifer Palomo, Sabina Troccaz, Dominique Talabot-Ayer, et al.
Arthritis and Rheumatism|January 30, 2010
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonistCéline Lamacchia, Gaby Palmer, Christian A Seemayer, et al.
Frontiers in Immunology|April 2, 2021
IL-1 Family Antagonists in Mouse and Human Skin InflammationPraxedis Martin, Jérémie D Goldstein, Loïc Mermoud, et al.
Journal of Leukocyte Biology|October 21, 2011
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promotersDominique Talabot-Ayer, Nicolas Calo, Solenne Vigne, et al.
Pageof 7